Study provides new look at why rare cancer often evades treatments
Por um escritor misterioso
Descrição
Researchers at Boston Medical Center and Dana-Farber Cancer Institute have conducted one of the first-ever analyses of neuroendocrine tumors (NETs) at single-cell resolution, unlocking new insights into this rare and often hard-to-treat cancer. The findings represent a tremendous leap forward in understanding why these tumors are largely resistant to immunotherapy and provide key insights that could lead to future treatments.
Center For Cancer Immunotherapy
The future of early cancer detection
Count Me In launches a rare cancer research project to engage leiomyosarcoma patients and families
We've Got You Covered: Rebooting American Health Care: Einav, Liran, Finkelstein, Amy: 9780593421239: : Books
Microbiome in cancer: Role in carcinogenesis and impact in therapeutic strategies - ScienceDirect
Spatial omics and multiplexed imaging to explore cancer biology
Scientists reveal how proteins drive growth of multiple cancer types – Washington University School of Medicine in St. Louis
Could CAR T-Cell Therapy Be a Cure for Some Cancers?
Study Provides New Look at Why Rare Cancer Often Evades Treatments
Does Having Cancer Once Increase the Risk of Developing Other Cancers? - Cancer Health